Beiland Pharmaceuticals: Obtained Drug Registration Certificate for Iodixanol Injection

K-LinePoet · 2026-03-16T14:03:48+00:00

Beilong Pharmaceutical announced that the company recently received the "Drug Registration Certificate" for Iodipamide Injection, issued and approved by the National Medical Products Administration. The original manufacturer of Iodipamide Injection is Bayer in Germany, and its indication is for diagnostic use. Iodipamide Injection has been included in the National Medical Insurance Category A drug list. According to data from Mininet, in China's three major terminal markets and six key regions, sales of Iodipamide Injection exceeded 1.6 billion yuan in 2024, and in the first quarter of 2025, sales grew at a rate of 2.78% to surpass 400 million yuan.

K-LinePoet

2026-03-16 14:03:48

Beilu Pharmaceutical announced that recently, the company received the Drug Registration Certificate approved and issued by the National Medical Products Administration for Iohexol Injection. The original manufacturer of Iohexol Injection is Bayer Germany. Indications: used for diagnostic purposes. Iohexol Injection has been included in the National Medical Insurance Category A drug list. According to data from Minai Network, in China’s three major terminal markets, the sales of Iohexol Injection exceeded 1.6 billion yuan in 2024, and in the first quarter of 2025, it grew by 2.78% to over 400 million yuan.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.